Medical nuclear radiation shielding dressing and radionuclide applicator

The medical nuclear radiation shielding dressing and composite layer structure radionuclide applicator formed by crosslinking nano-scale rare earth materials with polymers has solved the problem of lack of shielding protection and fixing effects in the prior art, and achieved the 32P The beta ray absorption and radiation protection in patch treatment provide an environmentally friendly and personalized treatment plan.

CN118903709APending Publication Date: 2024-11-08SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411169259.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing 32P patch treatment lacks shielding protection for normal skin around the lesions, and the fixation effect of the patch device is poor, which increases the risk of radiation exposure.

Method used

Medical nuclear radiation shielding dressings formed by crosslinking nanoscale rare earth materials or inorganic non-metallic materials with polymers, combined with radionuclide applicators with composite layer structures, provide effective β-ray absorption and flexible fixation.

Benefits of technology

Effectively absorb β-rays, reduce the radiation impact on the skin and environment around the lesions, provide reliable fixed and uniform radiation protection, and the material is environmentally friendly and non-toxic, suitable for personalized treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903709A_ABST
    Figure CN118903709A_ABST
Patent Text Reader

Abstract

The embodiment of the invention provides a medical nuclear radiation shielding dressing and a radionuclide applicator. The medical nuclear radiation shielding dressing and the radionuclide applicator are formed by a cross-linking reaction between a dispersion phase and a matrix continuous phase of a high-molecular polymer, wherein the dispersion phase takes a nano-scale rare earth material or a nano-scale inorganic non-metallic material which can effectively absorb nuclear radiation rays as a filler. The radiation shielding dressing disclosed by the invention can effectively absorb beta rays and reduce the influence of radiation on the skin and environment around a focus; compared with traditional heavy metal protection materials such as lead or lead-aluminum alloy, the radiation shielding dressing has good flexibility and viscoelasticity, can be conveniently shaped and reliably fixed in an area needing to be protected, and ensures uniformity and effectiveness of radiation protection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to the technical field of medical devices, and in particular to a medical nuclear radiation shielding dressing and a radionuclide applicator. Background Art

[0002] Phosphorus 32 is a pure beta decay nuclide, a radioactive isotope of the element phosphorus, with the symbol 32 P. Currently, nuclear medicine is widely used 32 P patch therapy is used to treat skin lesions such as skin hemangioma, keloid, hypertrophic scar, etc. 32 P patch therapy uses the beta rays produced by the decay of the radionuclide phosphorus 32 to cover and target the diseased area, thereby inhibiting the proliferation of fibroblasts and blood vessels, thereby achieving the purpose of lesion atrophy.

[0003] Current 32 P patch therapy uses a homemade applicator, which has only a layer of transparent film on its outer surface and lacks shielding protection for the normal skin around the lesion. Therefore, the surrounding normal skin may have adverse reactions due to excessive nuclear radiation. Furthermore, the applicator needs to be fixed in the correct position during the patch therapy to avoid unnecessary irradiation of normal skin tissue. However, most existing applicators are fixed with medical tape, which has poor fixing effect and is easy to shift, increasing the risk of radiation exposure. Summary of the invention

[0004] In order to solve the problems in the related art, the embodiments of the present disclosure provide a medical nuclear radiation shielding dressing and a radionuclide applicator to overcome at least one of the many deficiencies in the prior art.

[0005] In a first aspect, a medical nuclear radiation shielding dressing is provided in an embodiment of the present disclosure.

[0006] Specifically, the medical nuclear radiation shielding dressing is formed by cross-linking a dispersed phase of a filler made of nano-rare earth material or nano-inorganic non-metallic material that can effectively absorb nuclear radiation rays with a matrix continuous phase of a high molecular polymer.

[0007] Optionally, the dispersed phase is a nano hollow sphere powder having a microwave resonant cavity structure, and the specific gravity of the dispersed phase is less than 5 g / cm 3 .

[0008] Optionally, the high molecular polymer is polyurethane, polyvinyl alcohol, polyethylene glycol or polyacrylonitrile.

[0009] Optionally, a cross-linking aid is also included, and the cross-linking aid includes at least one of a rheology regulator, a coagulant and an active agent.

[0010] Optionally, the rheology regulator is carbomer, the coagulant is polyvinyl pyrrolidone, and the active agent includes vitamin A and vitamin B12.

[0011] Optionally, the formed dressing is characterized as a shielding membrane having a composite layer structure.

[0012] Optionally, the shielding film forms a composite layer structure of at least three layers, and the composite layer structure includes, from bottom to top, a first absorption shielding layer, a second absorption shielding layer and an adhesive layer.

[0013] Optionally, the first absorption shielding layer is a nano hollow sphere powder substrate, and the second absorption shielding layer is a polymer film layer in which the nano hollow sphere powder is uniformly dispersed.

[0014] Optionally, the formed dressing is characterized by a blend of fiber morphology and high molecular weight polymer.

[0015] In a second aspect, a radionuclide applicator is provided in an embodiment of the present disclosure, and the applicator includes:

[0016] Backing layer;

[0017] A first radiation shielding layer, the lower surface of which is attached to the backing layer;

[0018] a treatment liquid containing layer, configured to contain radioactive nuclides in a sealed manner, with a lower surface thereof being in contact with an upper surface of the backing layer;

[0019] An isolation layer covers the upper surface of the treatment liquid containing layer and the first radiation shielding layer, wherein:

[0020] The first radiation shielding layer is made of the medical nuclear radiation shielding dressing described in the aforementioned scheme.

[0021] Optionally, a second radiation shielding layer made of the same material as the first radiation shielding layer is provided between the isolation layer and the treatment accommodating layer, and the second radiation shielding layer is configured to completely cover the upper surface and periphery of the treatment accommodating layer.

[0022] Optionally, from the edges where the treatment fluid containing layer contacts the first radiation shielding layer, the thickness of the first radiation shielding layer gradually decreases in a direction away from the edges where the treatment fluid containing layer contacts the first radiation shielding layer.

[0023] Optionally, the treatment liquid containing layer is a flexible film layer made of transparent material.

[0024] The technical solution provided by the embodiments of the present disclosure may have the following beneficial effects:

[0025] The medical nuclear radiation shielding dressing disclosed herein can effectively absorb beta rays and reduce the impact of radiation on the skin and environment around the lesion; compared with traditional heavy metal protective materials such as lead or lead-aluminum alloy, the radiation shielding dressing has good flexibility and viscoelasticity, can be easily shaped and reliably fixed in the area that needs protection, ensuring the uniformity and effectiveness of radiation protection, and is more environmentally friendly.

[0026] The medical nuclear radiation shielding dressing disclosed herein is made of non-toxic and non-irritating materials, is skin-friendly, is not likely to cause allergic reactions, can directly contact the skin, has good chemical stability, and is easy to store.

[0027] In addition, the radionuclide applicator disclosed in the present invention can be shaped by adjusting the area and thickness of the applicator according to the different shapes and sizes of lesions to achieve personalized radiation protection; when in use, a uniform radiation shielding layer can be formed on the upper surface of the applicator and the skin around the lesion, which can effectively absorb the beta rays emitted from the applicator and protect the surrounding normal skin tissue and environment from radiation damage.

[0028] It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present disclosure. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Other features, objectives and advantages of the present disclosure will become more apparent through the following detailed description of non-limiting embodiments in conjunction with the accompanying drawings. In the accompanying drawings:

[0030] Figure 1 Scanning electron microscope showing the dispersed phase of the nuclear radiation dressing according to an embodiment of the present disclosure Figure 1 ;

[0031] Figure 2 A schematic diagram showing a composite layer structure of a nuclear radiation dressing according to an embodiment of the present disclosure is shown;

[0032] Figure 3 A scanning electron microscope showing a dispersed phase of a nuclear radiation dressing according to another embodiment of the present disclosure Figure 2 ;

[0033] Figure 4 A schematic structural diagram of a radionuclide applicator according to yet another embodiment of the present disclosure is shown;

[0034] Figure 5 A diagram showing an actual usage scenario of a radionuclide applicator according to yet another embodiment of the present disclosure.

[0035] It should be understood that the size of each component shown in the accompanying drawings is not drawn according to the actual proportional relationship. In addition, the same or similar reference numerals represent the same or similar components. DETAILED DESCRIPTION

[0036] Hereinafter, exemplary embodiments of the present disclosure will be described in detail with reference to the accompanying drawings so that those skilled in the art can easily implement them. In addition, for the sake of clarity, parts not related to the description of the exemplary embodiments are omitted in the accompanying drawings.

[0037] In the present disclosure, it should be understood that terms such as "include" or "have" are intended to indicate the presence of features, numbers, steps, behaviors, components, parts, or a combination thereof disclosed in the present specification, and are not intended to exclude the possibility that one or more other features, numbers, steps, behaviors, components, parts, or a combination thereof exist or are added.

[0038] It should also be noted that, in the absence of conflict, the embodiments and features in the embodiments of the present disclosure may be combined with each other. The present disclosure will be described in detail below with reference to the accompanying drawings and in combination with the embodiments.

[0039] As mentioned above, existing radionuclide patch therapy lacks shielding protection for the normal skin around the lesion, so the surrounding normal skin may have adverse reactions due to excessive nuclear radiation; existing radioactive materials mostly use heavy metal materials such as lead or lead-aluminum, which have poor plasticity. In addition, existing applicators are mostly fixed with medical tape, which has poor fixation effect and is easy to shift, increasing the risk of radiation exposure.

[0040] To solve the above problems, an embodiment of the present disclosure provides a nuclear radiation shielding dressing. Nano-scale rare earth materials or inorganic non-metallic materials that can effectively absorb nuclear radiation rays are used as the dispersed phase of the filler to undergo a cross-linking reaction with the matrix continuous phase of the polymer material to form a radiation shielding dressing that can effectively absorb β rays and reduce the impact of radiation on the skin and environment around the lesion; compared with traditional heavy metal protective materials such as lead or lead-aluminum alloy, the radiation shielding dressing has good flexibility and viscoelasticity, and can be easily shaped and reliably fixed in the area that needs protection.

[0041] Figure 1 A scanning electron microscope image showing a dispersed phase of a nuclear radiation shielding dressing according to an embodiment of the present disclosure.

[0042] The nuclear radiation shielding dressing is mainly formed by a dispersed phase, a matrix continuous phase and a cross-linking auxiliary agent through a cross-linking reaction.

[0043] The dispersed phase is composed of nanometer-scale fillers that can effectively absorb nuclear radiation rays (such as β rays, α rays or γ rays, etc.). The nanometer-scale fillers are used as nanometer-scale modifiers, and can be made of nanometer-scale rare earth materials and inorganic non-metallic materials, such as rare earth element materials such as lanthanide series or their compounds, borides, borates or aluminates, etc. Of course, other nanometer-scale materials that can effectively absorb β rays can also be selected, such as compounds containing low atomic number elements (such as polyethylene, organic glass, etc.). These materials can effectively slow down β rays and absorb their energy, thereby reducing radiation leakage.

[0044] According to one embodiment of the present disclosure, the nano-scale dispersed phase has a microwave resonant cavity structure, such as Figure 1 As shown, it is in the form of hollow spherical powder (or nano-beads), with a specific gravity of less than 5g / cm 3 (Lead is 11.39g / cm 3 ). After radiation testing, this radiation shielding dressing can demonstrate strong absorption and protection performance.

[0045] On the one hand, the quantum size effect of the nano-scale dispersed phase causes the electronic energy level to split. The spacing of some of the split energy levels is within the energy range of microwaves, which can produce efficient absorption channels, thereby absorbing and shielding nuclear radiation. In addition, nanoparticles have a high coercivity, which can cause hysteresis loss, which also increases the absorption efficiency to a certain extent. On the other hand, the single-particle resonant cavity structure can play a frequency-selective role in the energy of incident and transmitted rays. The incident energy can produce scattering, convergence or oscillation effects in its resonant cavity. Since the incident energy generates eddy current loss and magnetic and thermal losses in the resonant cavity, it affects the absorption and running trajectory of the incident energy, and plays a role in simultaneously absorbing and diffusely scattering and attenuating radiation rays with high efficiency.

[0046] The matrix continuous phase disclosed in the present invention adopts a high molecular polymer, for example, polyurethane, polyvinyl alcohol, polyethylene glycol or polyacrylonitrile, etc. The high molecular polymer is mild in nature, non-irritating and non-corrosive. By cross-linking the nano-scale dispersed phase with the high molecular material, a high-yield radiation-proof dressing with controllable composition and morphology can be synthesized, which meets the requirements of low energy consumption and no environmental pollution.

[0047] In order to further improve the physical properties of the dressing, such as appropriate rheology, adhesiveness, chemical stability and other properties, the present disclosure also adds a cross-linking auxiliary agent during the formation of the nuclear radiation shielding dressing to improve the compatibility between materials and ensure that the cross-linking process is controllable. Among them, the cross-linking auxiliary agent may include a rheology regulator, a coagulant and an active agent, etc. The present disclosure is only an exemplary description, and those skilled in the art can add other auxiliary agents according to the needs of actual application occasions.

[0048] Among them, the rheology regulator can be carbomer, so as to improve the rheology of the dressing and adjust its adhesiveness to meet the needs of practical applications. For example, appropriate rheology can facilitate shaping during treatment, and suitable adhesiveness can include reliable dressing fixation, eliminating the use of external tape.

[0049] The coagulant is polyvinyl pyrrolidone, which maintains good chemical stability and is not easily oxidized or decomposed, thereby prolonging the radiation protection effect.

[0050] Active agents include vitamin A and vitamin B12. The addition of active agents can promote skin healing and rapid repair.

[0051] The medical nuclear radiation shielding dressing disclosed in the present invention can form a polymer fiber material with controllable morphology or a composite layer shielding membrane by cross-linking a nano-scale dispersed phase with a high molecular polymer matrix continuous phase.

[0052] For example, the nuclear radiation shielding material of the present disclosure can be formed into a shielding membrane having a composite layer structure after being formed. Figure 2 As shown, the shielding membrane can be a composite film with a three-layer structure, and can include a first absorption shielding layer A, a second absorption shielding layer B and an adhesive layer C from top to bottom. The composition and structure of the first absorption shielding layer A and the second absorption shielding layer B can be the same, or they can be different. Preferably, different component forms are arranged between the two absorption shielding layers disclosed in the present invention. For example, absorption shielding layers with two functions can be made according to the different intensities of radiation rays, wherein the first layer A located at the bottom layer can be a nano hollow sphere powder base, and the second layer B structure located above the first layer can be arranged as a polymer film layer uniformly dispersed with nano hollow sphere powder, and the adhesive layer C located above the second layer, and all absorption layer components are orderly distributed in the shielding membrane. The thickness of the shielding membrane is not more than 2 mm, and the maximum shielding value can reach 250 keV. The radiation rays are gradually absorbed after passing through the first absorption shielding layer A and the second absorption shielding layer B in turn, so as to achieve rapid adsorption and removal of radioactive contamination on the surface of the object, and have strong protection ability.

[0053] According to another embodiment of the present disclosure, the dressing obtained by cross-linking the nano-dispersed phase with the polymer has spinnability. Based on this property, the morphology of the formed dressing of the present disclosure can be characterized as a blend of fiber morphology and polymer, such as Figure 3As shown. The nanomaterial is manufactured into a fiber filament form and is blended and cross-linked with a high molecular polymer, so that at least part of the high molecular polymer is precipitated on the fiber surface to form a shielding fabric coating. Exemplarily, the coating can be a rubber-type adhesive (such as nitrile rubber) material, and if necessary, it can be used in combination with different fillers, such as industrial carbon black, graphite, silicon carbide (corundum), nickel-doped steel powder, ferrite particles with a diameter of 0.1-10 μm, or other metals and their oxides.

[0054] In addition, high-energy radiation can cause ionization, photoelectric effect, and heat in the shielding layer, which greatly promotes the aging of polymer materials. Appropriate protective agents should be added. Due to processing and manufacturing needs, other additives should also be added, mainly coupling agents, protective agents, vulcanizers, softeners, stabilizers, and adhesives. Coupling agents are intermediary materials for blending non-metallic powder particles with polymer materials. Commonly used silicon coupling agents include KH550 (r-aminopropyl trioxyethyl silane), KH560 (r-glycidyloxypropyl trimethyl silane), and KH570. The protective agents used for polymer materials in radiation protection situations include N-phenyl-N-o-tolyl-p-phenylenediamine, β-phenylthelamine, N-phenyl-N'-isopropyl-p-phenylenediamine (antioxidant 4010NA), N-phenyl-N'cyclohexyl-p-phenylenediamine (antioxidant 4010) and 2,2'-methylenebis(4-methyl-6-tert-butylphenol) (antioxidant 2246). Vulcanizers are used in rubber matrices to fix the shielding layer particles in the formed network structure to obtain high elasticity and other mechanical properties. Vulcanizers include sulfur and corresponding accelerators and vulcanizers. Softeners can improve the plasticity of plastic or rubber matrices and are conducive to the uniform dispersion of non-metallic powders. Ortho-acid ester softeners are generally used. Stabilizers can ensure that non-metallic powders are evenly dispersed without precipitation and agglomeration.

[0055] According to another embodiment of the present disclosure, a radionuclide applicator is provided for treating skin lesions, wherein the radionuclide can be an isotope of phosphorus. 32 P.

[0056] The applicator of the present disclosure, such as Figure 4 As shown, it includes a backing layer 1, a first radiation shielding layer 2, a treatment liquid containing layer 3 and an isolation layer 4 arranged in sequence from bottom to top, wherein:

[0057] Backing layer 1, which can be a non-woven fabric with a specification of 60g / m 2 -80 g / m 2 , or it may be a polymer material film layer, such as a polyethylene film;

[0058] A first radiation shielding layer 2, the lower surface of which is peelably adhered to the backing layer 1, and the first radiation shielding layer 2 is made of a dressing capable of blocking and shielding nuclear radiation;

[0059] Specifically, the dressing is formed by cross-linking a dispersed phase of a nano-rare earth material or a nano-inorganic non-metallic material that can effectively absorb nuclear radiation as a filler with a continuous phase of a polymer matrix, wherein the dispersed phase of the rare earth material or the inorganic non-metallic material is a nano hollow sphere powder with a microwave resonant cavity structure, and the specific gravity of the dispersed phase is less than 5g / cm 3 ; The matrix continuous phase is made of high molecular polymer, for example, polyurethane, polyvinyl alcohol, polyethylene glycol or polyacrylonitrile, which is mild, non-irritating and non-corrosive. By cross-linking the nano-scale dispersed phase with the high molecular material, a high-yield radiation-proof dressing with controllable composition and morphology can be synthesized, which meets the requirements of low energy consumption, no environmental pollution and high yield.

[0060] The first radiation shielding layer 2 of the present disclosure is composed of a shielding film having a three-layer composite layer structure (such as Figure 2 As shown), it may include a first absorption shielding layer A, a second absorption shielding layer B and an adhesive layer C from top to bottom. Among them, the first layer A located at the bottom layer may be a nano hollow sphere powder substrate, and the second layer B structure located above the first layer may be configured as a polymer film layer uniformly dispersed with nano hollow sphere powder, and the adhesive layer C located above the second layer, all the absorption layer components are orderly distributed in the shielding film. The thickness of the shielding film is not more than 2mm, and the maximum shielding value can reach 250keV. In addition, the radiation shielding layer material disclosed in the present invention itself has adhesiveness, and the adhesiveness is appropriate and adjustable. No extra adhesive layer is required when in use, and it is easy to use.

[0061] The treatment liquid containing layer 3 is configured to contain radioactive nuclides in a sealed manner, and its lower surface is in contact with the upper surface of the backing layer 1. The treatment liquid containing layer 3 of the present disclosure is provided with a containing chamber, and the containing chamber is filled with radioactive nuclides. 32 P, and the radionuclide can exist in solid or liquid form, and of course it can also be present in the containing chamber in the form of a proper amount of radionuclide solution adsorbed by filter paper as a carrier. 32 The maximum range of P is 2 to 8 mm, and the effective penetration distance in the tissue is 2 to 3 mm. The present invention utilizes the beta rays generated by the decay of the radionuclide phosphorus 32 to cover and target the lesion area, thereby inhibiting the proliferation of fibroblasts and blood vessels, thereby achieving lesion atrophy.

[0062] The isolation layer 4 covers the upper surface of the treatment liquid containing layer 3 and the first radiation shielding layer 4. The isolation layer is located on the uppermost surface of the applicator and is in direct contact with the air. It can isolate the radiation shielding layer from the outside world to a certain extent and create a moist repair environment for the radiation shielding layer.

[0063] Optionally, a second radiation shielding layer 5 made of the same material as the first radiation shielding layer 1 is provided between the isolation layer 4 and the treatment accommodation layer 3, and the second radiation shielding layer 5 is configured to completely cover the upper surface and the periphery of the treatment accommodation layer 3. The second radiation shielding layer 5 can effectively block the diffusion of radioactive nuclides to the outside, thereby achieving the purpose of protection.

[0064] According to another embodiment of the present disclosure, taking into account the siphon effect of the edge of the radionuclide carrier filter paper, the radioactivity concentration at the edges of the treatment fluid containing layer 3 of the applicator will be higher than that in the center. The applicator of the present disclosure adopts a method in which the thickness of the first radiation shielding layer 2 gradually decreases in the direction away from the treatment fluid containing layer 3 from the edge where the first radiation shielding layer 2 contacts the treatment fluid containing layer 3, so as to further avoid damage to the surrounding normal skin due to unnecessary excessive radiation.

[0065] In addition, the treatment liquid containing layer 3 is a flexible film layer made of transparent material.

[0066] To ensure the transmittance of the therapeutic radiation energy light, the applicator can be designed to be transparent as a whole, for example, the treatment liquid containing layer and the radiation shielding layer can be made of highly transparent polymer materials. For example, the treatment liquid containing layer is made of a flexible film layer of transparent material such as polyurethane film.

[0067] In order to treat lesions of different shapes and sizes, the radionuclide applicator disclosed in the present invention can be configured as a flexible body as a whole, that is, it can be locally deformed within a certain range to meet the application of skin lesions of different shapes and sizes; of course, the applicator disclosed in the present invention can be prefabricated into applicators of various shapes and sizes to meet the needs of various application scenarios and achieve personalized treatment.

[0068] When the patch is used for treatment, the patient or medical staff peels off the backing layer of the patch, and then directly applies the patch to the surface of the scar tissue or skin hemangioma lesion, and applies appropriate pressure to ensure its stability.

[0069] The above description is only a preferred embodiment of the present disclosure and an explanation of the technical principles used. Those skilled in the art should understand that the scope of the invention involved in the present disclosure is not limited to the technical solution formed by a specific combination of the above technical features, but should also cover other technical solutions formed by any combination of the above technical features or their equivalent features without departing from the inventive concept. For example, the above features are replaced with the technical features with similar functions disclosed in the present disclosure (but not limited to) by each other.

Claims

1. A medical nuclear radiation shielding dressing, characterized in that: The method is formed by cross-linking a dispersed phase of a nanometer-scale rare earth material or a nanometer-scale inorganic non-metallic material that can effectively absorb nuclear radiation with a macromolecular polymer matrix continuous phase as a filler.

2. The dressing according to claim 1, characterized in that The dispersed phase is a nano hollow sphere powder with a microwave resonant cavity structure, and the specific gravity of the dispersed phase is less than 5g / cm 3 .

3. The dressing according to claim 1, characterized in that The high molecular polymer is polyurethane, polyvinyl alcohol, polyethylene glycol or polyacrylonitrile.

4. The dressing according to any one of claims 1 to 3, characterized in that The invention also comprises a cross-linking auxiliary agent, wherein the cross-linking auxiliary agent comprises at least one of a rheology regulator, a coagulant and an active agent.

5. The dressing according to claim 4, characterized in that in, The rheology regulator is carbomer, the coagulant is polyvinyl pyrrolidone, and the active agent includes vitamin A and vitamin B12.

6. The dressing according to any one of claims 1 to 3, characterized in that The formed dressing is characterized as a shielding membrane with a composite layer structure.

7. The dressing according to claim 6, characterized in that The shielding film forms at least a three-layer composite layer structure, and the composite layer structure includes a first absorption shielding layer, a second absorption shielding layer and an adhesive layer in sequence from bottom to top.

8. The dressing according to claim 7, characterized in that in, The first absorption shielding layer is a nano hollow sphere powder substrate, and the second absorption shielding layer is a polymer film layer in which the nano hollow sphere powder is uniformly dispersed.

9. The dressing according to any one of claims 1 to 3, characterized in that The formed dressing is characterized as a blend of fiber morphology and high molecular polymer.

10. A radionuclide applicator, characterized in that: Including setting from bottom to top: Backing layer; A first radiation shielding layer, the lower surface of which is attached to the backing layer; a treatment liquid containing layer, configured to contain radioactive nuclides in a sealed manner, with a lower surface thereof being in contact with an upper surface of the backing layer; An isolation layer covers the upper surface of the treatment liquid containing layer and the first radiation shielding layer, wherein: The first radiation shielding layer is made of the medical nuclear radiation shielding dressing according to any one of claims 1-9.

11. The applicator according to claim 10, characterized in that: A second radiation shielding layer made of the same material as the first radiation shielding layer is disposed between the isolation layer and the treatment accommodating layer. The second radiation shielding layer is configured to completely cover the upper surface and periphery of the treatment accommodating layer.

12. The applicator according to claim 10 or 11, characterized in that: From the edges where the treatment fluid containing layer contacts the first radiation shielding layer, the thickness of the first radiation shielding layer gradually decreases in a direction away from the edges where the treatment fluid containing layer contacts the first radiation shielding layer.

13. The applicator according to claim 10, characterized in that: The treatment liquid containing layer is a flexible film layer made of transparent material.